Cargando…
Pharmacologic IRE1/XBP1s Activation Confers Targeted ER Proteostasis Reprogramming
Activation of the IRE1/XBP1s signaling arm of the unfolded protein response (UPR) is a promising strategy to correct defects in endoplasmic reticulum (ER) proteostasis implicated in diverse diseases. However, no pharmacologic activators of this pathway identified to date are suitable for ER proteost...
Autores principales: | Grandjean, Julia M.D., Madhavan, Aparajita, Cech, Lauren, Seguinot, Bryan O., Paxman, Ryan J., Smith, Emery, Scampavia, Louis, Powers, Evan T., Cooley, Christina B., Plate, Lars, Spicer, Timothy P., Kelly, Jeffery W., Wiseman, R. Luke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502540/ https://www.ncbi.nlm.nih.gov/pubmed/32690944 http://dx.doi.org/10.1038/s41589-020-0584-z |
Ejemplares similares
-
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
por: Plate, Lars, et al.
Publicado: (2016) -
Pharmacologic IRE1/XBP1s activation promotes systemic adaptive remodeling in obesity
por: Madhavan, Aparajita, et al.
Publicado: (2022) -
Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis
por: Blackwood, Erik A., et al.
Publicado: (2019) -
Disruption of proteostasis causes IRE1 mediated reprogramming of alveolar epithelial cells
por: Katzen, Jeremy, et al.
Publicado: (2022) -
The IRE1α-XBP1 Signaling Axis Promotes Glycolytic Reprogramming in Response to Inflammatory Stimuli
por: English, Bevin C., et al.
Publicado: (2022)